Literature DB >> 8504927

Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II.

I Ha1, S Roberts, E Maldonado, X Sun, L U Kim, M Green, D Reinberg.   

Abstract

Transcription factor IIB (TFIIB) plays a pivotal role in the formation of transcription-competent initiation complexes. TFIIB was found to interact with the TATA-binding protein, the small subunit of TFIIF, and RNA polymerase II. These interactions require distinct domains in TFIIB. Using the gel mobility-shift assay, it was found that the amino terminus of TFIIB was necessary for the formation of complexes containing RNA polymerase II and TFIIF, whereas the carboxy-terminal domain, which is composed of two imperfect direct repeats and includes a putative amphipathic alpha-helix, was sufficient for the formation of complexes containing the TATA-binding protein and TFIIB (DB complex). Protein-protein interaction analyses demonstrate that the amphipathic alpha-helix in TFIIB is important for the interaction with the TATA-binding protein. Specific residues mapping to the carboxyl terminus of the second direct repeat were found to be crucial for the interaction of TFIIB and RNA polymerase II. The interaction with the small subunit of TFIIF was mapped to the amino terminus of TFIIB, which includes a zinc finger.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504927     DOI: 10.1101/gad.7.6.1021

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  95 in total

1.  Orientation of the transcription preinitiation complex in archaea.

Authors:  S D Bell; P L Kosa; P B Sigler; S P Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  DNA wrapping in transcription initiation by RNA polymerase II.

Authors:  B Coulombe
Journal:  Biochem Cell Biol       Date:  1999       Impact factor: 3.626

3.  The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.

Authors:  T C Kuhlman; H Cho; D Reinberg; N Hernandez
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  The two Saccharomyces cerevisiae SUA7 (TFIIB) transcripts differ at the 3'-end and respond differently to stress.

Authors:  B C Hoopes; G D Bowers; M J DiVisconte
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

5.  Activator-mediated disruption of sequence-specific DNA contacts by the general transcription factor TFIIB.

Authors:  R Evans; J A Fairley; S G Roberts
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

6.  Transcriptional repressor of vasoactive intestinal peptide receptor mediates repression through interactions with TFIIB and TFIIEbeta.

Authors:  L Pei
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

7.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Core promoter-dependent TFIIB conformation and a role for TFIIB conformation in transcription start site selection.

Authors:  Jennifer A Fairley; Rachel Evans; Nicola A Hawkes; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.

Authors:  J C Blanco; I M Wang; S Y Tsai; M J Tsai; B W O'Malley; P W Jurutka; M R Haussler; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  A common site on TBP for transcription by RNA polymerases II and III.

Authors:  Oliver Schröder; Gene O Bryant; E Peter Geiduschek; Arnold J Berk; George A Kassavetis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.